Clinical Trials Sponsored by Joergen Serup

Total 638 results

Joergen Serup
Zealand University Hospital

Recruiting

HIFU for Treatment of Non-nodular and Recurrent BCC (BCC-HIFU2101)

Carcinoma, Basal Cell

Denmark
Joergen Serup
Sahlgrenska University Hospital, Sweden

Active, not recruiting

HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy (cNF-HFU2101)

Cutaneous Neurofibroma

Denmark, Sweden
Statens Serum Institut

Completed

A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

Tuberculosis

South Africa
Statens Serum Institut

Completed

Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI

Tuberculosis

Spain
Statens Serum Institut

Completed

Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration

Tuberculosis

Denmark
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine (THYB-01)

Tuberculosis

Netherlands
Statens Serum Institut

Completed

A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG (TESEC-03)

Tuberculosis

United Kingdom
Statens Serum Institut

Completed

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) (TESEC-04)

Tuberculosis

South Africa
Statens Serum Institut

Completed

Treatment Study of Metronidazole to Treat Dientamoebiasis in Children (DFPT)

Dientamoebiasis

Denmark
Statens Serum Institut

Completed

A Safety and Dose Finding Trial of C-Tb, When Given to Adult Patients Recently Diagnosed With Active Tuberculosis (TESEC-02)

Tuberculosis

United Kingdom
Statens Serum Institut

Completed

Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers

Tuberculosis

Netherlands
Statens Serum Institut

Completed

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

Active Immunization

Poland
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers (THYB-02)

Tuberculosis

Netherlands
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31) (THYB-03)

Tuberculosis
Statens Serum Institut

Completed

Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses (TESEC-07)

Tuberculosis

South Africa
Statens Serum Institut

Completed

Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults

Healthy

Denmark
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) (C-011-404)

Tuberculosis

South Africa
Aeras
Statens Serum Institut

Completed

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB (C-037-456)

Tuberculosis

South Africa
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

Tuberculosis

Finland
Aeras
Statens Serum Institut

Completed

A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)

Latent Tuberculosis | Latent Tuberculosis Bacteriology and Histology Unknown

South Africa
Aeras
Statens Serum Institut

Completed

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

Latent Tuberculosis | Latent Tuberculosis Bacteriology and Histology Unknown

South Africa
Aeras
Statens Serum Institut

Completed

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Tuberculosis

Sweden
Hans Joergen Soegaard

Completed

Application of Psychiatric Knowledge in the Rehabilitation Process in Return to Work. (PKRW)

Mental Disorders

Denmark
Rigshospitalet, Denmark
Statens Serum Institut

Completed

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Neonatal Infection | Viral Infection | Neonatal Sepsis | Neonatal Death | Herpes Simplex Virus Infection | Newborn; Infection | Neonatal Herpes Simplex Infection | Neonatal HSV Infection

Denmark
Sibel Serap Ceylan

Completed

The Effect of Feeding Positions During Tube Feeding on Stress, Pain Level and Feeding Tolerance of Preterm Infants

Pain | Stress | Enteral Feeding Intolerance

Turkey
Serap Tekbas

Completed

Effect of Pelvic Floor Muscle Exercise on Sexual Function

Pelvic Floor Muscle Weakness | Sexuality

Turkey
Naestved Hospital
Statens Serum Institut

Completed

Plasma Transfusion in Major Vascular Surgery

Arterial Occlusive Diseases | Aortic Aneurysm, Abdominal

Denmark
Juergen Debus

Withdrawn

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation (GERAS)

Newly Diagnosed Glioblastoma in Patients ≥70 Years

Germany
Juergen Debus

Recruiting

Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors (NAVIGATORR)

Head and Neck Tumors

Germany
Juergen Debus

Recruiting

Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy (DILANA)

Anal Cancer

Germany
University of Bergen
Helse-Bergen HF

Completed

Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations

Psychotic Disorders

Norway
Bergen University College
University of Bergen

Unknown

The Effect of an Evidence-based Physiotherapy Regimen for Patients With Rotator Cuff Tendinopathy

Tendinopathy | Shoulder Impingement Syndrome | Shoulder Pain | Subacromial Impingement

Norway
Serum Institute of India Pvt. Ltd.

Active, not recruiting

Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence

Prevention of TB Recurrence

Bangladesh, India
Bergen University College
Helse-Bergen HF

Completed

Evaluation of Training in De-escalation

De-escalation Skills

Norway
Serum Institute of India Pvt. Ltd.

Recruiting

Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Hepatitis B Immunization | Diptheria Immunization | Tetanus Immunization | Pertussis Immunization | Haemophilus Influenzae Type B Immunization | Polio Immunization

Bangladesh, India
Serap Ozturk Altinayak

Completed

Acupressure and Comfort at Childbirth

Pain, Labor

Turkey
Serum Institute of India Pvt. Ltd.

Completed

Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age (ACYWX-04)

Vaccine for Meningococcal Disease

India
Serum Institute of India Pvt. Ltd.

Completed

Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India

Rotavirus Gastroenteritis

India
Statens Serum Institut
Imperial College London

Completed

Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years

Chlamydia Trachomatis

United Kingdom
Serum Institute of India Pvt. Ltd.

Recruiting

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants

Yellow Fever

Gambia, Mali
Serum Institute of India Pvt. Ltd.

Not yet recruiting

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Yellow Fever

Kenya
Serum Institute of India Pvt. Ltd.

Completed

Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Poliomyelitis

Bangladesh
Statens Serum Institut
Imperial College London

Completed

Safety and Immunogenicity of a Chlamydia Vaccine CTH522 (CHLM-02)

Trachoma

United Kingdom
Bandim Health Project
Statens Serum Institut

Completed

Trial of Two Strains of BCG (BCGSTRAIN)

Morbidity | Bacille Calmette-Guérin

Guinea-Bissau
Serap Ozturk Altinayak

Completed

Endorphin at Labor Pain and Acupressure

Labor Pain

Turkey
Aarhus University Hospital
Statens Serum Institut

Completed

Cohabitation Patterns and Incidence of Known and Suspected Sexually Transmitted Diseases

Sexually Transmitted Diseases | Cohabitation Patterns
University of Aarhus
Statens Serum Institut

Completed

Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar (FGS/MGS/STI)

Sexually Transmitted Infections | Schistosoma Haematobium

Madagascar
Juergen Debus

Recruiting

MR-guidance in Chemoradiotherapy for Cervical Cancer (AIM-C1)

Cervical Cancer

Germany
Jorgen Vestbo

Withdrawn

Vitamin D and Chronic Obstructive Lung Disease

Chronic Obstructive Lung Disease

Denmark
Serum Institute of India Pvt. Ltd.
PATH

Completed

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Meningococcal Meningitis

Gambia, Mali

3

Subscribe